SC
HUM icon

Scholtz & Company’s Humana HUM Stock Holding History

Scholtz & Company’s Portfolio HUM Stock Details HUM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,685
Closed -$3.1M – 58
2021
Q4 		$3.1M Sell
6,685
-15
-0.2% -$6.64K 1% 30
2021
Q3 		$2.61M Buy
6,700
+200
+3% +$84.9K 0.92% 34
2021
Q2 		$2.88M Buy
6,500
+212
+3% +$92.6K 0.98% 34
2021
Q1 		$2.64M Sell
6,288
-935
-13% -$373K 1% 33
2020
Q4 		$2.96M Sell
7,223
-79
-1% -$32.8K 1.16% 33
2020
Q3 		$3.02M Hold
7,302
– – 1.32% 30
2020
Q2 		$2.83M Buy
+7,302
New +$2.73M 1.41% 24
2019
Q1 		– Sell
-2,804
Closed -$803K – 57
2018
Q4 		$803K Buy
+2,804
New +$889K 0.7% 30

Other funds holding HUM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Scholtz & Company's HUM Position: Q1 2022 in Review

Scholtz & Company sold out of Humana (HUM) in Q1 2022, closing a stake of 6,685 shares — an estimated $3.1M sold.

Scholtz & Company first reported a position in HUM in Q4 2018 and held it in 8 quarters. The position peaked at $3.1M in Q4 2021. 914 funds tracked by Wall St. Rank hold HUM as of Q1 2022.

  • Scholtz & Company reported no remaining Humana position as of Q1 2022 after selling out during the quarter.
  • Scholtz & Company sold 6,685 Humana shares in Q1 2022, an estimated $3.1M.
  • Scholtz & Company first reported a position in Humana in Q4 2018 and held it in 8 quarters.
  • Scholtz & Company's Humana position peaked at $3.1M in Q4 2021.
  • 914 funds tracked by Wall St. Rank held Humana as of Q1 2022.

Based on Scholtz & Company's 13F filing for Q1 2022, filed 16 May 2022.